These data suggest that Slc25a49 deletion results in energy reprogramming by impaired mitochondrial OXPHOS and compensatory elevation of glycolysis, especially G6P levels, thereby exacerbating the progression of Dox‐induced cardiomyopathy. The gene discussed is MTCH1; the disease is cardiomyopathy.